Abstract
Subcutaneous injection of murine tumor cells first resulted in a state of severely suppressed macrophage-mediated antibacterial resistance and then in a contrasting state of greatly enhanced antibacterial resistance. Whereas, the state of suppressed antibacterial resistance corresponded to a state of suppressed resistance to a tumor cell challenge, the generation of enhanced antibacterial resistance corresponded to the acquisition of concomitant antitumor immunity. It was suggested on the basis of this evidence that changes in the level of macrophage-mediated antibacterial resistance that occur during growth of the primary tumor reflected changes in the level of the host's resistance to the tumor itself. It was further suggested that the coincidental suppression of antibacterial and antitumor resistance that occurs during the initial stages of growth of the primary tumor represents the operation of a mechanism that enables the tumor to avoid destruction by macrophages. The results support the view that macrophages play an important role in native and acquired resistance to malignant tumors.
Full Text
The Full Text of this article is available as a PDF (757.4 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Fioretti M. C., Libarati M., Bonmassar E., Cudkowicz G. Immune inhibition of allogeneic lymphoma cells in the peritoneal cavity of mice. Cancer Res. 1975 Jan;35(1):30–36. [PubMed] [Google Scholar]
- Germain R. N., Williams R. M., Benacerraf B. Specific and nonspecific antitumor immunity. II. Macrophage-mediated nonspecific effector activity induced by BCG and similar agents. J Natl Cancer Inst. 1975 Mar;54(3):709–720. [PubMed] [Google Scholar]
- Hibbs J. B., Jr, Lambert L. H., Jr, Remington J. S. In vitro nonimmunologic destruction of cells with abnormal growth characteristics by adjuvant activated macrophages. Proc Soc Exp Biol Med. 1972 Mar;139(3):1049–1052. doi: 10.3181/00379727-139-36295. [DOI] [PubMed] [Google Scholar]
- Kearney R., Basten A., Nelson D. S. Cellular basis for the immune response to methylcholanthrene-induced tumors in mice. Heterogeneity of effector cells. Int J Cancer. 1975 Mar 15;15(3):438–450. doi: 10.1002/ijc.2910150310. [DOI] [PubMed] [Google Scholar]
- Keller R. Mechanisms by which activated normal macrophages destroy syngeneic rat tumour cells in vitro. Cytokinetics, non-involvement of T lymphocytes, and effect of metabolic inhibitors. Immunology. 1974 Aug;27(2):285–298. [PMC free article] [PubMed] [Google Scholar]
- Magarey C. J., Baum M. Reticulo-endothelial activity in humans with cancer. Br J Surg. 1970 Oct;57(10):748–752. doi: 10.1002/bjs.1800571013. [DOI] [PubMed] [Google Scholar]
- OLD L. J., CLARKE D. A., BENACERRAF B., GOLDSMITH M. The reticuloendothelial system and the neoplastic process. Ann N Y Acad Sci. 1960 Jun 21;88:264–280. doi: 10.1111/j.1749-6632.1960.tb20026.x. [DOI] [PubMed] [Google Scholar]
- Robinette E. H., Jr, Mardon D. N. Delayed lethal response to Candida albicans infection in mice bearing the Lewis lung carcinoma. J Natl Cancer Inst. 1975 Sep;55(3):731–733. doi: 10.1093/jnci/55.3.731. [DOI] [PubMed] [Google Scholar]